Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
-
Authors :
Bromage DI; The Hatter Cardiovascular Institute, University College London, 67 Chenies Mews, London, WC1E 6HX, UK.; School of Cardiovascular Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, James Black Centre, 125 Coldharbour Lane, London, SE5 9NU, UK.
Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*therapeutic use ; Metformin/Metformin/Metformin/*therapeutic use
-
Source:
Cardiovascular diabetology [Cardiovasc Diabetol] 2019 Dec 09; Vol. 18 (1), pp. 168. Date of Electronic Publication: 2019 Dec 09.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840
تفاصيل العنوان
Subjects: Antidiabetic agents; Heart failure; Ischaemic cardiomyopathy
-
Source:
Godec , T R , Bromage , D I , Pujades-Rodriguez , M , Cannatà , A , Gonzalez-Izquierdo , A , Denaxas , S , Hemingway , H , Shah , A M ,
-
تفاصيل العنوان